Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AMGN | VRTX | REGN | GILD |
| Company | Bristol-Myers Squibb Company | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 44.68 | 265.72 | 393.52 | 881.72 | 65.50 |
| High | 45.37 | 271.68 | 399.68 | 887.48 | 66.35 |
| Low | 44.34 | 265.72 | 393.49 | 875.22 | 64.63 |
| Last | 44.85 | 269.98 | 397.48 | 883.20 | 65.42 |
| Change | +0.15 | +0.60 | -0.22 | -7.48 | +0.15 |
| % Change | +0.34% | +0.22% | -0.06% | -0.84% | +0.23% |
| Volume | 21,281,900 | 2,436,900 | 682,400 | 505,600 | 12,382,400 |
| 20-Day Average Volume | 13,205,370 | 2,156,940 | 943,625 | 457,100 | 7,062,390 |
| Previous Close | 44.70 | 269.38 | 397.70 | 890.68 | 65.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 49.47 | 269.99 | 401.28 | 918.54 | 68.29 |
| 20-Day Raw Stochastic | 5.16% | 40.03% | 21.25% | 8.40% | 9.20% |
| 20-Day Relative Strength | 29.15% | 45.47% | 42.53% | 33.09% | 29.21% |
| Weighted Alpha | -34.43 | +9.45 | +14.78 | +9.82 | -23.49 |
| Today's Opinion | 88% Sell | 72% Sell | 8% Buy | 8% Sell | 100% Sell |
| Previous Opinion | 88% Sell | 72% Sell | 8% Buy | 8% Buy | 100% Sell |
| Last Month's Opinion | 8% Buy | 40% Buy | 56% Buy | 80% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.34% since 04/19/24 | +0.39% since 04/19/24 | +0.81% since 04/19/24 | -1.52% since 04/19/24 | -2.01% since 04/19/24 |
| Low | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 | 64.63 on 04/26/24 |
| High | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 | 67.90 on 04/25/24 |
| 1-Month | |||||
| %Chg | -14.65% since 03/26/24 | -4.18% since 03/26/24 | -5.01% since 03/26/24 | -8.34% since 03/26/24 | -9.65% since 03/26/24 |
| Low | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 64.63 on 04/26/24 |
| High | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -9.76% since 01/26/24 | -13.40% since 01/26/24 | -7.60% since 01/26/24 | -6.05% since 01/26/24 | -17.73% since 01/26/24 |
| Low | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 64.63 on 04/26/24 |
| High | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 80.00 on 01/29/24 |
| 6-Month | |||||
| %Chg | -15.33% since 10/26/23 | +0.10% since 10/26/23 | +10.02% since 10/26/23 | +11.51% since 10/26/23 | -16.66% since 10/26/23 |
| Low | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 769.19 on 10/27/23 | 64.63 on 04/26/24 |
| High | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 90,900,144 | 144,810,784 | 102,732,288 | 96,941,800 | 81,452,936 |
| Shares Outstanding, K | 2,026,759 | 536,376 | 258,459 | 109,762 | 1,245,077 |
| Annual Sales | 45,006,000,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | 8,025,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 11,477,000,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 7,114,000,000 |
| Last Quarter Net Income | 1,762,000,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | 1,429,000,000 |
| 60-Month Beta | 0.39 | 0.58 | 0.35 | 0.11 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.40 on 04/25/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | 04/04/24 | 05/16/24 | N/A | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 6.08 | 14.44 | 29.59 | 23.70 | 16.20 |